Login
Drugs & Diseases
News & CME
E-Learning
MENU
About MIMS Treatment Guidelines
+
Anxiety Overview
Symptoms
Treatment
Patient Education
+
Arrhythmias Overview
Symptoms
Treatment
Patient Education
+
Asthma Overview
Symptoms
Treatment
Patient Education
+
Attention-Deficit/Hyperactivity Disorder (ADHD) Overview
Symptoms
Treatment
Patient Education
+
Bipolar Disorder Overview
Symptoms
Treatment
+
Breast Cancer Overview
Symptoms
Treatment
+
Bronchitis - Chronic in Acute Exacerbation Overview
Symptoms
Treatment
Patient Education
+
Bronchitis - Uncomplicated Acute Overview
Symptoms
Treatment
Patient Education
+
Chlamydia Overview
Symptoms
Treatment
Patient Education
+
Chronic Obstructive Pulmonary Disease Overview
Symptoms
Treatment
Patient Education
+
Dengue Overview
Symptoms
Treatment
Patient Education
+
Depression Overview
Symptoms
Treatment
Patient Education
+
Diabetes Mellitus Overview
Symptoms
Treatment
Patient Education
+
Dyslipidemia Overview
Symptoms
Treatment
Patient Education
+
Dyspepsia Overview
Symptoms
Treatment
Patient Education
+
Endometriosis Overview
Symptoms
Treatment
+
Gastroesophageal Reflux Disease (GERD) Overview
Symptoms
Treatment
Patient Education
+
Gout Overview
Symptoms
Treatment
Patient Education
+
Hepatitis Overview
Symptoms
Treatment
Patient Education
+
HIV Overview
Symptoms
Treatment
+
Hypertension Overview
Symptoms
Treatment
Patient Education
+
Infective Endocarditis Overview
Symptoms
Treatment
+
Insomnia Overview
Symptoms
Treatment
Patient Education
+
Lung Cancer Overview
Symptoms
Treatment
+
Measles Overview
Symptoms
Treatment
+
Melanoma Overview
Symptoms
Treatment
Patient Education
+
Neuropathic Pain Overview
Symptoms
Treatment
+
Parkinson's Disease Overview
Symptoms
Treatment
-
Rheumatoid Arthritis Overview
Symptoms
Treatment
Patient Education
+
Scabies Overview
Symptoms
Treatment
Patient Education
+
Schizophrenia Overview
Symptoms
Treatment
+
Vertigo Overview
Symptoms
Treatment
Patient Education
Symptoms
Â
Treatment Guidelines
/
Rheumatoid Arthritis Overview
/
Symptoms
MIMS treatment guidelines
About MIMS Treatment Guidelines
Anxiety Overview
Symptoms
Treatment
Patient Education
Arrhythmias Overview
Symptoms
Treatment
Patient Education
Asthma Overview
Symptoms
Treatment
Patient Education
Attention-Deficit/Hyperactivity Disorder (ADHD) Overview
Symptoms
Treatment
Patient Education
Bipolar Disorder Overview
Symptoms
Treatment
Breast Cancer Overview
Symptoms
Treatment
Bronchitis - Chronic in Acute Exacerbation Overview
Symptoms
Treatment
Patient Education
Bronchitis - Uncomplicated Acute Overview
Symptoms
Treatment
Patient Education
Chlamydia Overview
Symptoms
Treatment
Patient Education
Chronic Obstructive Pulmonary Disease Overview
Symptoms
Treatment
Patient Education
Dengue Overview
Symptoms
Treatment
Patient Education
Depression Overview
Symptoms
Treatment
Patient Education
Diabetes Mellitus Overview
Symptoms
Treatment
Patient Education
Dyslipidemia Overview
Symptoms
Treatment
Patient Education
Dyspepsia Overview
Symptoms
Treatment
Patient Education
Endometriosis Overview
Symptoms
Treatment
Gastroesophageal Reflux Disease (GERD) Overview
Symptoms
Treatment
Patient Education
Gout Overview
Symptoms
Treatment
Patient Education
Hepatitis Overview
Symptoms
Treatment
Patient Education
HIV Overview
Symptoms
Treatment
Hypertension Overview
Symptoms
Treatment
Patient Education
Infective Endocarditis Overview
Symptoms
Treatment
Insomnia Overview
Symptoms
Treatment
Patient Education
Lung Cancer Overview
Symptoms
Treatment
Measles Overview
Symptoms
Treatment
Melanoma Overview
Symptoms
Treatment
Patient Education
Neuropathic Pain Overview
Symptoms
Treatment
Parkinson's Disease Overview
Symptoms
Treatment
Rheumatoid Arthritis Overview
Symptoms
Treatment
Patient Education
Scabies Overview
Symptoms
Treatment
Patient Education
Schizophrenia Overview
Symptoms
Treatment
Vertigo Overview
Symptoms
Treatment
Patient Education
Symptoms
Clinical Manifestations
Signs and Symptoms
Joint pain
Morning stiffness lasting >1 hr
Myalgia, fatigue, weight loss, low-grade fever, depression
Typically involves the joints of the fingers, wrists, toes
Upper & lower extremity joints are also affected (eg shoulders, elbows, knees & ankles)
Syndrome of polymyalgia rheumatica may occasionally be present
Physical Findings
Joint pain & swelling are the key features of early rheumatoid arthritis
Hand & foot involvements are common in the early course of RA
Symmetric polyarthritis involving the metacarpophalangeal, metatarsophalangeal, &/or proximal interphalangeal (PIP) joints of the hands strongly suggest RA
Deformities due to joint & tendon destruction are late manifestations of RA:
Ulnar deviation or drift
Boutonnière & swan-neck deformities
Hammer toes
Joint ankylosis (uncommon)
Genu varus or valgus may also be seen secondary to erosion of femoral condyles & tibial plateau
Top
Diagnosis
Based on clinical signs & symptoms, lab results & imaging features
New Classification Criteria for RA:
Developed by the American College of Rheumatology (ACR) Board of Directors & European League Against Rheumatism (EULAR) Executive Committee
Can be applied to patients at more than one point in the evolution of their signs & symptoms
Limited only to patients w/ clinical synovitis in at least 1 joint & synovitis not secondary to other disease
A total score of ≥6/10 is needed to classify a patient as having definite RA
Number & site of involved joints
5 points for >10 joints, including at least 1 small joint
1
3 points for 4-10 small joints
1
2 points for 1-3 small joints
1
1 point for 2-10 large joints (eg shoulders, elbows, hips, knees, ankles)
Serological abnormality (at least 1 test result is needed)
3 points for high-positive [>3x upper limit of normal (ULN)] rheumatoid factor (RF) or anti-citrullinated protein antibody (ACPA)
2 points for low-positive (≤3x ULN) RF or ACPA
Acute-phase reactants abnormality (at least 1 test result is needed)
1 point for abnormal C-reactive protein (CRP) or erythrocyte sedimentation rate (ESR)
Symptom duration
1 point for ≥6 wk
Differential Diagnoses
Systemic diseases
Rheumatic fever
Infective endocarditis
Still’s disease
Sarcoidosis
Other connective tissue syndromes
Scleroderma
Systemic lupus erythematosus
Systemic vasculitides
Spondyloarthropathies
Psoriatic arthritis
Reactive arthritis
Infectious arthritis
Crystal-induced arthritis
Endocrinopathies
Fibromyalgia
Osteoarthritis
Hemochromatosis
Paraneoplastic syndromes
Lab Exams
Rheumatoid factor (RF)
Present in approx 60-80% of patients w/ RA
Not recommended in monitoring patients w/ RA but useful in diagnosis esp if measured w/ ACPA
RF titers rarely change w/ disease activity
Anti-citrullinated protein antibody (ACPA)
Shows similar diagnostic sensitivity as RF but w/ higher specificity rate of approx 95-98%
Acute phase reactants
ESR & CRP are not specific for RA but reflect the degree of synovial inflammation
Monitoring of these acute phase reactants can be used to assess disease activity
CBC
May show anemia of chronic disease, leukocytosis & thrombocytosis
Synovial fluid analysis
Shows characteristics of inflammatory fluid w/ low glucose, low C3 & C4 complement levels
Synovial fluid glucose, complement or protein levels are not routinely measured due to their limited clinical use
Important to determine the total cell count
Imaging Studies
X-ray
Commonly used to assess the presence of joint damage secondary to RA
Early changes include soft-tissue swelling & juxta-articular demineralization
Later changes involve erosions through the cortex of the bone & around the margins of the joint
Decreased sensitivity if taken during the 1st 6 mth of the course of the disease
Magnetic resonance imaging (MRI)
More sensitive than standard radiography for detecting bone destruction
Detects bone erosions earlier in the course of the disease
Ultrasonography
Alternative method to estimate the degree of inflammation & volume of inflamed tissue
As w/ MRI, shows features of joint inflammation that is not physically evident, & detect bone erosions in early disease
May also be used to assess metatarsophalangeal joints & for intra-articular steroid injections
1
Eg metacarpophalangeal joints, PIP joints, 2nd-5th metatarsophalangeal joints, thumb interphalangeal joint, wrists
Top
Clinical Remission
Two definitions are proposed by the American College of Rheumatology/European League Against Rheumatism to define clinical remission in RA
These are suggested to be used in clinical trials as an outcome measure
Definition of Remission in RA Clinical Trials
Boolean-based definition - may be done at any time point, patient should have all of the ff:
Tender joint count ≤1 (include feet & ankles in the evaluation of the joints)
Swollen joint count ≤1 (include feet & ankles in the evaluation of the joints)
CRP ≤1 mg/dL
Patient global assessment ≤1 (on a scale of 0-10)
Based on the patient’s current feeling about their disease & on physician’s assessment of the patient’s current disease activity
Index-based definition - at any time point, patient should have a Simplified Disease Activity Index (SDAI) score of ≤3.3
Assessment of Disease Activity
Several indices are developed to assess disease activity which are useful in monitoring the response to therapy & in defining remission
Scores are categorized to low, moderate & high disease activity
Eg Disease Activity Score in 28 points, SDAI, Clinical Disease Activity Index, Rheumatoid Arthritis Disease Activity Index, PAS of PASII, Routine Assessment Patient Index Data
Disease Activity Score 28 (DAS28)
Assesses the patient’s RA disease by measuring the following:
Number of swollen joints in the hands, wrists, shoulders, knees & elbows
Serum erythrocyte sedimentation rate (ESR) & C-reactive protein (CRP)
Visual Analogue Score to analyze patient’s assessment on their level of pain & discomfort on the day of examination
The results are combined & assessed based on the total score:
<2.6: Disease remission
2.6-3.2: Low disease activity
3.2-5.1: Moderate disease activity
>5.1: High disease activity
Top
â—€Rheumatoid Arthritis Overview
Rheumatoid Arthritis Treatmentâ–¶